Klaas has extensive international chair and board experience following a 25 year career in venture capital.
From 2006 until 2021, he was the Managing Partner of Entrepreneurs Fund, where his portfolio included companies such as inge GmbH (sold to BASF), Technolas Perfect Vision (sold to Bausch & Lomb), Prosonix Ltd (sold to Circassia), Lifeline Scientific Inc (sold to Genext), New Motion (sold to Shell) and Optinose (Nasdaq IPO).
He currently chairs AIM-listed Xeros Technology Group plc and soon to be NASDAQ listed General Fusion, Inc., and serves on the Board of NASDAQ listed SmartKem, Inc. Klaas is also an independent advisor to the investment committee of the British Business Bank.
LinkedIn